Pfizer Limited (NSEI: PFIZER)
Health Care · Pharmaceuticals · IN
Rs3,808.20
+1.55% today · -27.7% 1Y
Pfizer Limited (NSEI: PFIZER) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.80B and employs 1,244 people.
Over the last twelve months the share price has lost 27.7%, trading between 3.73K and 5.58K.
Tweenvest scores Pfizer Limited across four factors: quality 87/100, value 83/100, growth 39/100, dividend 71/100. Its strongest factor is quality.
PFIZER price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.80B
- Revenue (TTM)
- $271.78M
- P/E
- 23.70
- EPS
- 160.70
- Dividend yield
- 2.00%
- Beta (5Y)
- 0.13
- 52-week high
- Rs5,578.50
- 52-week low
- Rs3,731.00
- Avg volume (3M)
- —
- Shares outstanding
- 45.75M
- Employees
- 1,244
- Next earnings
- —
About Pfizer Limited
Pfizer Limited operates as a pharmaceutical company, engaged in the development, promotion, sale, and international export of medicinal products. Its diverse product range addresses numerous therapeutic needs, such as those related to the neuro/central nervous system, hormonal balance, cardiovascular health, hemophilia, infectious diseases, gynecology, pain relief, orthopedic conditions, oncology, urology, parasitic infections, gastrointestinal disorders, vaccinations, respiratory ailments, and nutritional supplements. The company markets its offerings predominantly under various brand names through an extensive network of independent distributors. Established in 1950, its corporate headquarters are situated in Mumbai, India.
- ISIN
- INE182A01018
- Founded
- 1950
- Listed since
- Jul 1, 2002
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| The United Laboratories International Holdings LimitedSEHK: 3933 | $1.89B | HK$7.52 | +0.07% |
| Trevi Therapeutics, Inc.NasdaqGM: TRVI | $1.88B | $13.19 | 0.00% |
| Beijing Aosaikang Pharmaceutical Co., Ltd.SZSE: 002755 | $1.85B | CN¥13.34 | -1.55% |
| Structure Therapeutics Inc.NasdaqGM: GPCR | $1.82B | $24.74 | -3.15% |
| Septerna, Inc.NasdaqGM: SEPN | $1.79B | $37.96 | -1.07% |
| Neuren Pharmaceuticals LimitedASX: NEU | $1.79B | AU$20.20 | -0.39% |
| Zhejiang Medicine Co., Ltd.SHSE: 600216 | $1.78B | CN¥12.59 | +1.29% |
| Tsumura & Co.TSE: 4540 | $1.78B | ¥3,772.00 | +1.86% |
Figures last refreshed Oct 11, 2026.